Genoptix Reports Strong Financial Results for First Qu...(9175 4637 Gross profit ...),Health

Gross profit 13,123 6,014

Operating expenses:

Sales and marketing expenses 4,261 2,321

General and administrative expenses 4,388 2,134

Research and development expenses 317 178

Total operating expenses 8,966 4,633

Income from operations 4,157 1,381

Interest income 931 48

Interest expense - (82)

Other income 28 29

Income before income taxes 5,116 1,376

Provision for income taxes (109) (51)

Net income $5,007 $1,325

Net income per share: (1)(2)

Basic $0.31 $ -

Diluted $0.29 $ -

Shares used to compute net income per share: (1)(2)

Basic 16,156 154

Diluted 17,493 154

(1) As a result of the conversion of the Company's preferred stock into

11,032 shares of common stock upon completion of the Company's initial

public offering in November 2007, there is a lack of comparability in

the basic and diluted net income per share amounts for the periods

presented above.

(2) For the three months ended March 31, 2007, the Company's net income of

$1,325 was allocated to preferred stockholders for purposes of

calculating net income per share pursuant to the terms of the

p
'/>"/>